美中嘉和获控股股东上海医学之星增持4.56万股H股

格隆汇2025-05-07

格隆汇5月7日丨美中嘉和(02453.HK)公告，公司控股股东(定义见香港联合交易所有限公司证券上市规则之一医学之星(上海)企业管理有限公司知会公司董事会，上海医学之星于2025年5月7日以每股6.84港元的价格从公开市场购入合共4.56万股公司H股，总对价为311,904.00港元，占截至本公告日期本公司已发行股份总数约0.01%。此举充分体现上海医学之星对公司未来前景的信心和对公司持续发展的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2533937315?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-07 22:43","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2533937315","market":"hk","top_or_hot":-1,"title":"美中嘉和获控股股东上海医学之星增持4.56万股H股","media":"格隆汇","content":"<div>\n<p>格隆汇5月7日丨美中嘉和(02453.HK)公告，公司控股股东(定义见香港联合交易所有限公司证券上市规则之一医学之星(上海)企业管理有限公司知会公司董事会，上海医学之星于2025年5月7日以每股6.84港元的价格从公开市场购入合共4.56万股公司H股，总对价为311,904.00港元，占截至本公告日期本公司已发行股份总数约0.01%。此举充分体现上海医学之星对公司未来前景的信心和对公司持续发展的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224313a6d6795f&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美中嘉和获控股股东上海医学之星增持4.56万股H股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美中嘉和获控股股东上海医学之星增持4.56万股H股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-07 22:43 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224313a6d6795f&s=b><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇5月7日丨美中嘉和(02453.HK)公告，公司控股股东(定义见香港联合交易所有限公司证券上市规则之一医学之星(上海)企业管理有限公司知会公司董事会，上海医学之星于2025年5月7日以每股6.84港元的价格从公开市场购入合共4.56万股公司H股，总对价为311,904.00港元，占截至本公告日期本公司已发行股份总数约0.01%。此举充分体现上海医学之星对公司未来前景的信心和对公司持续发展的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224313a6d6795f&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02453","symbol_name":"美中嘉和","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224313a6d6795f&s=b","article_id":"2533937315","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507224313a6d6795f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2533937315","pubTimestamp":1746628993,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"此举充分体现上海医学之星对公司未来前景的信心和对公司持续发展的支持。据上海医学之星告知，其对集团的业务前景及增长充满信心。在符合适用的法律及监管要求的情况下，上海医学之星不排除会在自本公告日期起6个月内的适当时候通过于公开市场上购买公司额外H股进一步增持公司股份。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02453":"美中嘉和","BK1209":"保健护理机构"},"translate_title":"Meizhong Jiahe received an increase of 45,600 H shares held by controlling shareholder Shanghai Medical Star","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02453":1},"content_text":"格隆汇5月7日丨美中嘉和(02453.HK)公告，公司控股股东(定义见香港联合交易所有限公司证券上市规则之一医学之星(上海)企业管理有限公司知会公司董事会，上海医学之星于2025年5月7日以每股6.84港元的价格从公开市场购入合共4.56万股公司H股，总对价为311,904.00港元，占截至本公告日期本公司已发行股份总数约0.01%。此举充分体现上海医学之星对公司未来前景的信心和对公司持续发展的支持。据上海医学之星告知，其对集团的业务前景及增长充满信心。在符合适用的法律及监管要求的情况下，上海医学之星不排除会在自本公告日期起6个月内的适当时候通过于公开市场上购买公司额外H股进一步增持公司股份。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2533937315","isCrawlerRequest":true}